Human Umbilical Cord Blood (RegeneCyte) Infusion in Patients with Post-COVID Syndrome
Clinical trial NCT05682560 · COMPLETED
Trial details
- NCT number
- NCT05682560
- Sponsor
- StemCyte, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-04
- Primary completion
- 2024-07-26
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.